|
|
|
|
BiomedReports: News and FDA Updates for Sciences International (N...
Companies: BioDelivery Sciences International, Inc.(BDSI), Biogen Idec Inc (BIIB), China Sky One Medical Inc (CSKI) BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a...
|
|
|
Long-Term Data on DES Use in STEMI Patients Raise Concerns
ATLANTA, GALong-term follow-up from 2 randomized trials sheds light on the risk of late events with drug-eluting stents (DES) in patients with ST-segment elevation myocardial infarction (STEMI).One trial shows a higher rate of cardiac mortality, while the...
|
|
|
China Sky One Medical Receives CE Mark Approval for Myocardial Infarction and Urine Microalbumin Diagnostic Ki
HARBIN, China, March 19 /PRNewswire-Asia-FirstCall/ China Sky One Medical, Inc.('China Sky One Medical' or 'the Company') (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the Peopleescape_start39;s...
|
|
|
China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification
China Sky One Medical, Inc.("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the receipt of Conformite...
|
|
|
Updates for Sciences International (Nasdaq:BDSI), Biogen (NASDAQ:BIIB), China Sky (Nasdaq:CSKI)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
Updates for Sciences International (Nasdaq:BDSI), Biogen (NASDAQ:BIIB), China Sky (Nasdaq:CSKI)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and...
|
|
|
China Sky One Medical Receives CE Mark Approval for Myocardial Infarction and Urine Microalbumin Diagnostic Kits
HARBIN, China, March 19 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc.("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ...
|
|
|
China Sky One Medical Receives CE Mark Approval for Myocardial Infarction and Urine Microalbumin Diagnostic Ki
HARBIN, China The Company also received ISO 9001 and ISO 13485 certifications for its Myocardial Infarction, Urine Microalbumin and Early Pregnancy Diagnostic Kits.ISO certifications set stringent, globally recognized management system standard that...
|
|
|
Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI
Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of...
|
|
|
ACC: Is treatment equality protocol needed to reduce post-MI mortality in women?
ATLANTA--Women might be more likely to survive a heart attack if they were treated more like men, with increased use of PCI and other invasive techniques, according to a trial presented today during the late-breaking clinical trials session at the American...
|
|
|
More Research Needed to Determine Best Treatment of Multi-Vessel Coronary Artery Disease During Primary PCI for ST-Segment Elevation Myocardial Infarction
Companies mentioned in this article: Cardiac Data Solutions, Inc.ATLANTA, March 18 /PRNewswire/ -- Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel...
|
|
|
Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction
Whrle J et al.Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction.
|
|
|
Effect of Cyclosporine on Left Ventricular Remodeling After Reperfused Myocardial Infarction
Mewton N et al.Effect of Cyclosporine on Left Ventricular Remodeling After Reperfused Myocardial Infarction.
|
|
|
Stroke Epidemiology: Harvard University, Department of Environmental Health details research in stroke epidemiology
Today's Medical & Research News Stroke Epidemiology Harvard University, Department of Environmental Health details research in stroke epidemiology March 14th, 2010 Printer-Friendly Version City:Boston State:MA Country:United States Stroke Epidemiology...
|
|
|
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Imp
Nicoline J.Breet, MD; Jochem W. van Werkum, MD, PhD; Heleen J. Bouman, MSc; Johannes C. Kelder, MD; Henk J. Ruven, PhD; Egbert T. Bal, MD; Vera H. Deneer, PharmD, PhD; Ankie M. Harmsze, PharmD; Jan A. van der Heyden, MD; Benno J. Rensing,...
|
|
|
Cost-Effectiveness Analysis of Short-Term Clopidogrel Therapy for ST Elevation Myocardial Infarction
Circulation, 02/23/10 Relevance Score: 69% Journal of Cardiovascular Pharmacology and Therapeutics, 02/05/10 Relevance Score: 69% The American Journal of Cardiology, 02/26/10 Relevance Score: 68% Journal of Electrocardiology, 02/16/10 Relev Cost-Effectiveness...
|
|
|
A Novel Approach to Transplanting Bone Marrow Stem Cells to Repair Human Myocardial Infarction: Delivery via a Noninfarct-relative Artery
Bone marrow stem cells are able to repair infarcted human myocardium following intracoronary transplantation via the infarct-relative artery.However, traditional reperfusion strategies fail to open the artery in some patients, making effective delivery...
|
|
|
ST-segment Elevation Myocardial Infarction in Severe Coronary Artery Stenosis: A Case Series. March 01, 2010
_ ST-segment Elevation Myocardial Infarction in Severe Coronary Artery Stenosis: A Case Series.March 01, 2010.
|
|
|
Atherotech to exhibit VAP Cholesterol Test at ACC 2010
Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session Exposition. The annual meeting takes...
|
|
|
Acute Myocardial Infarction Hospitalization in the United States, 1979 to 2005
Fang J et al.During the past quarter century, hospitalization for acute myocardial infarction increased until the mid1990s, but has declined since then. At the same time, inhospital casefatality rates declined steadily. Acute Myocardial Infarction...
|
|
|
Atherotech's Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
BIRMINGHAM, Ala., March 8 /PRNewswire/ -- Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session...
|
|
|
Atherotech's Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
VAP(R) Cholesterol Test on exhibit at Atlanta Conference BIRMINGHAM, Ala., March 8 /PRNewswire/ -- Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American...
|
|
|
Atherotech's Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session Exposition. The annual meeting takes...
|
|
|
Atherotech's Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session Exposition. The annual meeting takes...
|
|
|
Atherotech's Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
Atherotech Inc.today announced it will be presenting research in two poster sessions and exhibiting its VAP Cholesterol Test in booth #1311 at the American College of Cardiology (ACC) 59th Annual Scientific Session Exposition. The annual meeting takes...
|
